We are live on ! Find out more
HPCM

High Pointe Capital Management Portfolio holdings

AUM $139M
1-Year Est. Return 24.99%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+24.99%
3 Year Est. Return
+92.38%
5 Year Est. Return
+133.03%
10 Year Est. Return
–
AUM
$70.1M
AUM Growth
-$2.65M
Cap. Flow
-$4.75M
Cap. Flow %
-6.77%
Top 10 Hldgs %
26.21%
Holding
92
New
5
Increased
4
Reduced
38
Closed
11

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$782K
2
SRCL
Stericycle Inc
SRCL
+$582K
3
AZN icon
AstraZeneca
AZN
+$493K
4
QCOM icon
Qualcomm
QCOM
+$397K
5
NVO
Novo Nordisk
NVO
+$352K

Top Sells

Rank Stock Value
1
JLL icon
Jones Lang LaSalle
JLL
+$1.34M
2
SBUX icon
Starbucks
SBUX
+$1.28M
3
SRE icon
Sempra
SRE
+$1.15M
4
ZTS icon
Zoetis
ZTS
+$1M
5
AAPL icon
Apple
AAPL
+$819K

Sector Composition

Rank Sector Weight
1 Healthcare 20.02%
2 Financials 18.24%
3 Technology 11.59%
4 Communication Services 9.9%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BKR icon
51
Baker Hughes
BKR
$58.3B
$525K 0.75%
15,900
– –
NVS icon
52
Novartis
NVS
$302B
$480K 0.68%
7,098
-156
-2% -$10.8K
DEO icon
53
Diageo
DEO
$49.6B
$467K 0.67%
3,240
-80
-2% -$11.5K
QVCGA
54
DELISTED
QVC Group Inc Series A
QVCGA
$463K 0.66%
450
– –
HPQ icon
55
HP
HPQ
$26B
$459K 0.65%
20,250
– –
AZ
56
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
$456K 0.65%
22,070
-500
-2% -$10.3K
LKQ icon
57
LKQ Corp
LKQ
$6.72B
$439K 0.63%
13,770
– –
TSM icon
58
TSMC
TSM
$1.94T
$434K 0.62%
11,870
-280
-2% -$11.1K
EMR icon
59
Emerson Electric
EMR
$81.6B
$425K 0.61%
6,150
– –
META icon
60
Meta Platforms (Facebook)
META
$1.49T
$405K 0.58%
2,085
– –
SONY icon
61
Sony
SONY
$137B
$386K 0.55%
37,650
-700
-2% -$6.81K
TTE icon
62
TotalEnergies
TTE
$193B
$377K 0.54%
6,220
-110
-2% -$6.74K
NTR icon
63
Nutrien
NTR
$33.9B
$376K 0.54%
6,906
-160
-2% -$7.94K
NVO
64
Novo Nordisk
NVO
$228B
$341K 0.49%
+14,800
New +$352K
AMX icon
65
America Movil
AMX
$74.6B
$321K 0.46%
19,270
-480
-2% -$8.31K
WST icon
66
West Pharmaceutical
WST
$23.7B
$310K 0.44%
3,120
– –
AEM icon
67
Agnico Eagle Mines
AEM
$72.2B
$305K 0.43%
6,650
-140
-2% -$6.16K
SIMO icon
68
Silicon Motion
SIMO
$7.11B
$297K 0.42%
5,620
-120
-2% -$5.89K
RDS.A
69
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$289K 0.41%
4,180
-70
-2% -$4.85K
AMZN icon
70
Amazon
AMZN
$2.44T
$280K 0.4%
3,300
– –
UBS icon
71
UBS Group
UBS
$170B
$260K 0.37%
16,960
-360
-2% -$5.86K
BABA icon
72
Alibaba
BABA
$276B
$249K 0.36%
1,340
-20
-1% -$3.81K
UNH icon
73
UnitedHealth
UNH
$382B
$245K 0.35%
1,000
– –
CX icon
74
Cemex
CX
$16.9B
$228K 0.33%
34,796
-820
-2% -$5.19K
LBTYA icon
75
Liberty Global Class A
LBTYA
$3.59B
$216K 0.31%
7,840
-170
-2% -$5.13K
1 2
3
4

Similar funds

COF
Capital One Financial Mclean, Virginia $141M AUM 2.36% 1-Year Est. Return
TC
Tatro Capital Lexington, Kentucky $134M AUM 3.29% 1-Year Est. Return
FFA
Freedman Financial Associates Peabody, Massachusetts $145M AUM 6.97% 1-Year Est. Return
NWM
Nauset Wealth Management Westport, Connecticut $126M AUM
KCA
Karn Couzens & Associates Farmington, Connecticut $157M AUM 11.36% 1-Year Est. Return
RCM
RVB Capital Management Great Neck, New York $117M AUM 17.05% 1-Year Est. Return
SIS
SVB Investment Services Salt Lake City, Utah $161M AUM 4.97% 1-Year Est. Return
MWM
Midwest Wealth Management Indianapolis, Indiana $165M AUM 19.98% 1-Year Est. Return

High Pointe Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, High Pointe Capital Management held 92 positions worth $70.1M, down 3.6% from $72.8M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

High Pointe Capital Management withdrew a net $4.75M in Q2 2018, closing 11 positions and reducing 38 holdings. Its most notable exit was Jones Lang LaSalle, an estimated $1.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

Against the trend, High Pointe Capital Management opened a new position in Regeneron Pharmaceuticals worth $862K.

  • High Pointe Capital Management's largest Q2 2018 buy was Regeneron Pharmaceuticals: 2,500 shares worth $862K.
  • High Pointe Capital Management added most to AstraZeneca in Q2 2018, an estimated $493K increase.
  • High Pointe Capital Management's biggest Q2 2018 reduction was Alphabet (Google) Class C, cutting an estimated $75.6K.
  • High Pointe Capital Management fully exited Jones Lang LaSalle in Q2 2018, selling an estimated $1.34M.
  • High Pointe Capital Management's ten largest holdings make up 26% of its $70.1M portfolio in Q2 2018.
  • High Pointe Capital Management opened 5 new positions and closed 11 in Q2 2018.
  • High Pointe Capital Management's portfolio value fell 3.6% quarter-over-quarter to $70.1M.

Based on High Pointe Capital Management's 13F filing for Q2 2018, filed 8 Aug 2018.